neuroblastoma


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

neu·ro·blas·to·ma

 (no͝or′ō-blă-stō′mə, nyo͝or′-)
n. pl. neu·ro·blas·to·mas or neu·ro·blas·to·ma·ta (-mə-tə)
A malignant tumor composed of neuroblasts, originating in the autonomic nervous system or the adrenal medulla and occurring chiefly in infants and young children.

neuroblastoma

(ˌnjʊərəʊblæsˈtəʊmə)
n, pl -mata (-matə) or -mas
(Pathology) pathol a malignant tumour that derives from neuroblasts, occurring mainly in the adrenal gland

neu•ro•blas•to•ma

(ˌnʊər oʊ blæˈstoʊ mə, ˌnyʊər-)

n., pl. -mas, -ma•ta (-mə tə)
a malignant tumor of immature nerve cells, most often affecting the young.
[1905–10]

neuroblastoma

a highly malignant tumor that may develop from the neural plate in an embryo and spread to the bones, liver, and other organs.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.neuroblastoma - malignant tumor containing embryonic nerve cells; usually metastasizes quickly
malignant neoplasm, malignant tumor, metastatic tumor - a tumor that is malignant and tends to spread to other parts of the body
Translations
neuroblastooma
neuroblastoma

neuroblastoma

n neuroblastoma m
References in periodicals archive ?
Shirley, aged 62, who joined the Board of Trustees at Neuroblastoma UK in 2006 says, "September is Childhood Cancer Awareness Month and it's also the month we lost Joanna, so what better incentive to take on this challenge in her memory.
[USPRwire, Wed Aug 21 2019] This report by MRRSE Research analyzes the global Pediatric Neuroblastoma Treatment Market for the period between 2018 and 2026.
[ClickPress, Wed Aug 21 2019] This report by MRRSE Research analyzes the global Pediatric Neuroblastoma Treatment Market for the period between 2018 and 2026.
Archie's parents, Simon and Harriet Wilks, have been told that almost half of children who complete treatment for neuroblastoma will relapse and, of those whose cancer returns, nine out of 10 will not survive.
She added: "We are absolutely delighted the latest scan result shows Kira's neuroblastoma to be responding well to the experimental inhibitor drug Lorlatini."
Neuroblastoma is the most common non-brain solid tumor in children.
Biotechnology company United Therapeutics Corporation (NASDAQ:UTHR) reported on Thursday the receipt of the Health Canada's approval for the combination of Unituxin (dinutuximab for injection), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for neuroblastoma.
Neuroblastoma (NB) is the most common extracranial solid tumor in children, arising from neural crest cells that differentiate to the sympathetic ganglia and adrenal medulla.[1],[2] The occurrence of NB is unusual in adolescents and adults.[3] Metastatic NB in children older than one year is still associated with a poor prognosis, as the majority of these patients, after an initial response to chemotherapy, suffer relapse of drug-resistant disease.
In March 2008 doctors found a huge tumour growing near Sienna's adrenal gland, and diagnosed neuroblastoma - a cancer that forms in nerve Little Sienna tissue.
Claire continued: "The oncologist said, 'We can't be certain until she gets the biopsy, but I think it's neuroblastoma.' "That was the moment when our lives changed forever.